Pancreatic Cancer Research

ResearcherZhengzhou UniversityActive in the last 2 years

Pan Liu

Matched on ORCID iD 0000-0002-6999-6550; OpenAlex author ID A5102743712. Sources: OpenAlex.

Their work

Papers
7 (first author 2, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
8
Papers, trials and grants by year

2017: 1 paper · 2018: none · 2019: none · 2020: 2 papers · 2021: none · 2022: 1 paper · 2023: 1 paper · 2024: 2 papers

Papers 7

  1. Identification of the Genetic Association Between Ferroptosis and immune in Pancreatic Cancer First author DOI 10.21203/rs.3.rs-3927756/v1↗
  2. Inhibition Effect of Pancreatic Exocrine Insufficiency on Immune Checkpoint Inhibitor Treatment in Pancreatic Cancer: A Retrospective Study. Co-author DOI 10.2147/itt.s442247↗
  3. Immortalization-upregulated protein promotes pancreatic cancer progression by regulating NPM1/FHL1-mediated cell-cycle-checkpoint protein activity. Co-author DOI 10.1007/s10565-022-09695-4↗
  4. Identifying cancer cell-secreted proteins that activate cancer-associated fibroblasts as prognostic factors for patients with pancreatic cancer. Co-author DOI 10.1111/jcmm.17596↗
  5. Long noncoding RNA EPIC1 interacts with YAP1 to regulate the cell cycle and promote the growth of pancreatic cancer cells. First author DOI 10.1016/j.bbrc.2019.11.167↗
  6. Curcumin enhances anti‑cancer efficacy of either gemcitabine or docetaxel on pancreatic cancer cells. Co-author DOI 10.3892/or.2020.7713↗
  7. Synergistic effects of baicalein with gemcitabine or docetaxel on the proliferation, migration and apoptosis of pancreatic cancer cells. Co-author DOI 10.3892/ijo.2017.4153↗

Closest collaborators

The 8 strongest of 8 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Tao Qin · 5 shared papers, 2020–2024 · strength 0.86
  2. Qiankun Luo · 5 shared papers, 2020–2024 · strength 0.86
  3. Hongwei Zhang · 4 shared papers, 2020–2024 · strength 0.64
  4. Xu Zhang · 2 shared papers, 2022–2024 · strength 0.35
  5. Lei Chen · 1 shared paper, 2024 · strength 0.22
  6. Liang Shao · 2 shared papers, 2017–2020 · strength 0.18
  7. Xinyi Li · 1 shared paper, 2020 · strength 0.13
  8. Peng Xia · 1 shared paper, 2020 · strength 0.11

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.